IBBJ FAQ
6 questionsWhat does Defiance Nasdaq Junior Biotechnology ETF do?
The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.Where does IBBJ stock trade?
Defiance Nasdaq Junior Biotechnology ETF (IBBJ) is listed on NASDAQ.What sector and industry is IBBJ in?
Defiance Nasdaq Junior Biotechnology ETF operates in the n/a sector.When did Defiance Nasdaq Junior Biotechnology ETF go public?
Defiance Nasdaq Junior Biotechnology ETF (IBBJ) completed its IPO in n/a.What companies are similar to IBBJ?
Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare IBBJ side-by-side with any of them on Quantisnow.How can I track IBBJ on Quantisnow?
Quantisnow aggregates Defiance Nasdaq Junior Biotechnology ETF's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IBBJ to receive live email and push alerts on every new disclosure.